Dynavax Technologies (DVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 32,073 | 32,688 | 60,485 | 37,899 | 39,884 |
| Marketable Securities | 132,963 | 144,473 | 140,223 | 91,634 | 111,171 |
| Receivables | 22,661 | 35,023 | 903 | 8,135 | 8,886 |
| Inventories | 63,689 | 59,033 | 54,392 | 48,099 | 41,332 |
| TOTAL | $290,015 | $290,003 | $265,466 | $194,147 | $208,653 |
| Non-Current Assets | |||||
| PPE Net | 30,567 | 30,379 | 30,476 | 30,897 | 32,022 |
| Intangibles | 2,297 | 2,196 | 2,103 | 2,263 | 4,581 |
| Other Non-Current Assets | 30,393 | 30,817 | 31,269 | 31,949 | 33,812 |
| TOTAL | $63,257 | $63,392 | $63,848 | $65,109 | $70,415 |
| Total Assets | $353,272 | $353,395 | $329,314 | $259,256 | $279,068 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,312 | 5,273 | 2,695 | 4,557 | 9,278 |
| Accrued Expenses | 21,904 | 20,131 | 15,577 | 15,521 | 18,922 |
| Other current liabilities | 13,983 | 19,509 | 34,950 | 9,201 | 24,847 |
| TOTAL | $77,411 | $66,625 | $53,222 | $29,279 | $53,047 |
| Non-Current Liabilities | |||||
| Long Term Debt | 179,811 | 179,733 | 179,656 | 179,583 | 178,601 |
| Deferred Revenues | 38,212 | 21,712 | N/A | N/A | N/A |
| aiOther Non-Current Liabilities | 37,357 | 37,753 | 38,141 | 38,570 | 39,130 |
| TOTAL | $217,168 | $217,486 | $217,797 | $218,153 | $217,731 |
| Total Liabilities | $294,579 | $284,111 | $271,019 | $247,432 | $270,778 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 113,256 | 110,173 | 109,512 | 92,184 | 86,189 |
| Common Shares | 110 | 110 | 109 | 88 | 84 |
| Retained earnings | -1,294,064 | -1,278,597 | -1,282,998 | -1,231,419 | -1,218,824 |
| Other shareholders' equity | 273 | -1,022 | -2,095 | -2,575 | -2,387 |
| TOTAL | $58,693 | $69,284 | $58,295 | $11,824 | $8,290 |
| Total Liabilities And Equity | $353,272 | $353,395 | $329,314 | $259,256 | $279,068 |